ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1027

Evaluation of Health Disparities in Outcomes of Patients with Juvenile Idiopathic Arthritis

Julia Harris1, Jade Singleton2 and Sheetal Vora3, 1Children's Mercy Kansas City, Overland Park, KS, 2Seattle Children's Hospital, Seattle, 3Atrium Health Levine Children's Hospital, Charlotte, NC

Meeting: ACR Convergence 2024

Keywords: Disparities, Juvenile idiopathic arthritis, Outcome measures, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Healthcare Disparities in Rheumatology Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Juvenile idiopathic arthritis (JIA) is a chronic autoimmune disease complicated by significant morbidity and disability with suboptimal rates of prolonged remission, decreased health-related quality of life, and functional limitations. The Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) is a 23-site North American pediatric rheumatology learning health network with a focus on improving outcomes in patients with JIA. PR-COIN has a centralized patient registry with over 13,500 registered patients and over 89,000 visits of patients with JIA to track outcome and process measures. We aimed to assess for health disparities in our collaborative JIA population by evaluating our performance on disease activity outcomes, overall wellbeing, and pain by race, ethnicity, age, sex assigned at birth, and JIA subtype.

Methods: We performed a retrospective analysis of all patients registered in the PR-COIN registry with at least one visit from April 2011 to March 2024 with patient data from 18 children’s hospitals. If patients had more than one visit in the registry, we selected the data from the most recent visit. We calculated the follow-up length of the latest visit to the diagnosis date and excluded patients with a disease duration of less than 6 months. We then conducted a cross-sectional analysis to estimate the association between race-ethnicity groups and health outcomes including physician global assessment of disease activity score, patient/parent global assessment of overall well-being score, active joint count, 10-joint clinical Juvenile Arthritis Disease Activity Score (cJADAS10), and arthritis-related pain score.

Results: Data from 9,601 patients were analyzed. 61.9% of patients with JIA identified as non-Hispanic White, 4.3% as Black or African American, 7.1% as Hispanic, 2.9% as Other, and 23.7% were unknown (Table 1). Table 2 highlights demographic and disease characteristics by race and ethnicity group. When controlling for race/ethnicity, sex assigned at birth, and JIA subtype, age was positively and significantly associated with higher scores of arthritis-related pain, physician global assessment of disease activity, patient/parent global assessment of overall well-being, active joint count, and cJADAS10 (Table 3). Non-Hispanic Black patients with JIA had statistically higher cJADAS10 scores compared to non-Hispanic Whites, in addition to statistically higher arthritis-related pain scores, physician global assessment of disease activity values, patient/parent global assessment of overall well-being scores, and active joint count values. Females had statistically higher scores compared to males for all outcome variables assessed. Furthermore, when compared to patients with the oligoarticular persistent JIA subtype, patients with polyarticular and psoriatic subtypes had significantly higher scores for pain, overall wellbeing, and disease activity outcomes.

Conclusion: We found disparities in outcomes of patients with JIA related to race, sex, and age. This information is imperative to drive further improvement efforts and enhance care coordination to close disparity gaps and improve outcomes for all patients with JIA.    

Supporting image 1

Table 1. Summary of patients by disease duration and race and ethnicity group.

Supporting image 2

Table 2. Characteristics of JIA population by race and ethnicity group.

Supporting image 3

Table 3. Adjusted associations between race/ethnicity and outcomes when controlling for age, sex assigned at birth, and JIA subtype.


Disclosures: J. Harris: None; J. Singleton: None; S. Vora: None.

To cite this abstract in AMA style:

Harris J, Singleton J, Vora S. Evaluation of Health Disparities in Outcomes of Patients with Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/evaluation-of-health-disparities-in-outcomes-of-patients-with-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-health-disparities-in-outcomes-of-patients-with-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology